Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis

Low selectivity of chemotherapy correlates with poor outcomes of cancer patients. To improve this issue, a novel agent, N-(1-[3-methoxycarbonyl-4-hydroxyphenyl]-β-carboline-3-carbonyl)-Trp-Lys-OBzl (PZL318), was reported here. The transmission electron microscopy, scanning electron microscopy, and a...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Nanomedicine
Auteurs principaux: Li, Shan, Wang, Yuji, Wang, Feng, Wang, Yaonan, Zhang, Xiaoyi, Zhao, Ming, Feng, Qiqi, Wu, Jianhui, Zhao, Shurui, Wu, Wei, Peng, Shiqi
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2015
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554418/
https://ncbi.nlm.nih.gov/pubmed/26345234
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S88052
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires